The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Open accessAbstract
While non-alcoholic fatty liver disease (NAFLD) is highly prevalent (15% to 45%) in modern societies, only 10% to 25% of cases develop hepatic fibrosis leading to cirrhosis, end-stage liver disease or hepatocellular carcinoma. Apart from pre-existing fibrosis, the strongest predictor of fibrotic progression in NAFLD is steatohepatitis or non-alcoholic steatohepatitis (NASH). The critical features other than steatosis are hepatocellular degeneration (ballooning, Mallory hyaline) and mixed inflammatory cell infiltration. While much is understood about the relationship of steatosis to metabolic factors (over-nutrition, insulin resistance, hyperglycemia, metabolic syndrome, hypoadiponectinemia), less is known about inflammatory recruitment, despite its importance for the perpetuation of liver injury and fibrogenesis. In this review, we present evidence that liver inflammation has prognostic significance in NAFLD. We then consider the origins and components of liver inflammation in NASH. Hepatocytes injured by toxic lipid molecules (lipotoxicity) play a central role in the recruitment of innate immunity involving Toll-like receptors (TLRs), Kupffer cells (KCs), lymphocytes and neutrophils and possibly inflammasome. The key pro-inflammatory signaling pathways in NASH are nuclear factor-kappa B (NF-κB) and c-Jun N-terminal kinase (JNK). The downstream effectors include adhesion molecules, chemokines, cytokines and the activation of cell death pathways leading to apoptosis. The upstream activators of NF-κB and JNK are more contentious and may depend on the experimental model used. TLRs are strong contenders. It remains possible that inflammation in NASH originates outside the liver and in the gut microbiota that prime KC/TLR responses, inflamed adipose tissue and circulating inflammatory cells. We briefly review these mechanistic considerations and project their implications for the effective treatment of NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–235 of 235
Leclercq (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000220 · Cited by 78
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis†
Caldwell, S. H., de Freitas, L. A. R., Park, S. H., Moreno, M. L. V., Redick, J. A., Davis, C. A., Sisson, B. J., Patrie, J. T., Cotrim, H. P., Argo, C. K., et al. (2009) · Hepatology · doi:10.1002/hep.22851 · Cited by 76
Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways
Larter, C. Z., Yeh, M. M., Haigh, W. G., Williams, J., Brown, S., Bell-Anderson, K. S., Lee, S. P., & Farrell, G. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.011 · Cited by 73
Self-citationGórnicka, A., Morris‐Stiff, G. J., Thapaliya, S., Papouchado, B. G., Berk, M. P., & Feldstein, A. E. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3815 · Cited by 73
Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice
Yu, J. Q., Chu, E. S., Wang, R., Wang, S., Wu, C. W., Wong, V. W., Chan, H. L., Farrell, G. C., & Sung, J. J. �. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.058 · Cited by 72
Self-citationDysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis
Rinella, M. E., Siddiqui, S. M., Gardikiotes, K., Gottstein, J. H., Elias, M. S., & Green, R. M. (2011) · Hepatology · doi:10.1002/hep.24553 · Cited by 72
Fatty Liver Disease NASH and Related Disorders
Hughes, R. D. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200606000-00020 · Cited by 71
Larter, C. Z., Yeh, M. M., Cheng, J., Williams, J., Brown, S., Dela Pena, A., Bell‐Anderson, K. S., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05157.x · Cited by 70
Self-citationNontriglyceride Hepatic Lipotoxicity: The New Paradigm for the Pathogenesis of NASH
Neuschwander‐Tetri, B. A. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0083-6 · Cited by 68
Lee, G. S., Yan, J. S., Ng, R., Kakar, S., & Maher, J. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700181-jlr200 · Cited by 68
Llacuna, L., Fernández, A., von Montfort, C., Matías, N., Martínez-Gili, L., Caballero, F., Rimola, A., Elena, M., Morales, A., Fernández-Checa, J. C., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.031 · Cited by 62
Park, S. H., Kim, B. I., Kim, S. H., Kim, H. J., Park, D. I., Cho, Y. K., Sung, I. K., Sohn, C. I., Kim, H. Y., Keum, D. K., et al. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719618 · Cited by 59
Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease
Soon, R. K., Yan, J. S., Grenert, J. P., & Maher, J. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.046 · Cited by 58
Angulo, P. (2011) · Hepatology · doi:10.1002/hep.24403 · Cited by 57
Brenner, D. A., Seki, E., Taura, K., Kisseleva, T., Deminicis, S., Iwaisako, K., Inokuchi, S., Schnabl, B., Oesterreicher, C., Paik, Y. H., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00814.x · Cited by 55
Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury
Ellett, J. D., Evans, Z. P., Atkinson, C., et al. (2009) · Liver Transplantation · doi:10.1002/lt.21782 · Cited by 55
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
Machado, M. V., & Cortez‐Pinto, H. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.16 · Cited by 53
Kirovski, G., Gäbele, E., Dorn, C., Moleda, L., Niessen, C., Weiß, T. S., Wobser, H., Schacherer, D., Buechler, C., Wasmuth, H. E., et al. (2010) · PubMed · doi:10.5283/epub.37048 · Cited by 53
Krysiak, R. G., Żmuda, W., & Okopień, B. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02394.x · Cited by 52
Peňa, A. D., Leclercq, I. A., Williams, J., & Farrell, G. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.025 · Cited by 49
Self-citationNew Insights from Rodent Models of Fatty Liver Disease
Maher, J. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3749 · Cited by 47
TNF-α is not the cause of fatty liver disease in obese diabetic mice
Memon, R. A., Grünfeld, C., & Feingold, K. R. (2001) · Nature Medicine · doi:10.1038/83316 · Cited by 44
Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
Ginsberg, H. N. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.010 · Cited by 43
A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis
Adams, L. A., Angulo, P., Petz, J., Keach, J. C., & Lindor, K. D. (2010) · Hepatology International · doi:10.1007/s12072-010-9195-1 · Cited by 31
Harris, R. B. S., & Leibel, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.007 · Cited by 31
Syn, W., Yang, L., Chiang, D. J., Qian, Y., Jung, Y., Karaca, G., Choi, S. S., Witek, R. P., Omenetti, A., Pereira, T. A., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02036.x · Cited by 29
Chan, J., Sharkey, F. E., Kushwaha, R. S., VandeBerg, J. F., & VandeBerg, J. L. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00415.2011 · Cited by 28
Lipidomic Dissection of Nonalcoholic Steatohepatitis: Moving Beyond Foie Gras to Fat Traffic
Bass, N. M. (2009) · Hepatology · doi:10.1002/hep.23458 · Cited by 27
Caldwell, S. H., Redick, J. A., Chang, C., Davis, C. A., Argo, C. K., & Abdullah, K. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00627_8.x · Cited by 26
Vijay‐Kumar, M., Aitken, J. D., Carvalho, F. A., Ziegler, T. R., Gewirtz, A. T., & Ganji, V. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-2 · Cited by 26
Fatty Acid Metabolism and Lipotoxicity in the Pathogenesis of NAFLD/NASH
Bass, N. M., & Merriman, R. B. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch9 · Cited by 16
Histological features of non‐alcoholic fatty liver disease: What is important?
Hashimoto, E., Tokushige, K., & Farrell, G. C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06957.x · Cited by 16
Self-citationLiver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease
Targher, G., & Day, C. P. (2010) · Hepatology · doi:10.1002/hep.23901 · Cited by 16
Chitturi, S., & Farrell, G. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05977.x · Cited by 7
Self-citationLeclercq, I. A., Rooyen, D. M. V., Farrell, G. C., Kowdley, K. V., McCaughan, G. W., & Trautwein, C. (2010) · Hepatology · doi:10.1002/hep.24661 · Cited by 6
Self-citation
Cited by
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Nakagawa, H., Umemura, A., Taniguchi, K., Font-Burgada, J., Dhar, D., Ogata, H., Zhong, Z., Valasek, M. A., Seki, E., Hidalgo, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.001 · Cited by 525
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
Asgharpour, A., Cazanave, S. C., Pacana, T., Seneshaw, M., Vincent, R., Banini, B. A., Kumar, D. P., Daita, K., Min, H.-K., Mirshahi, F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.005 · Cited by 538
Porras, D., Nistal, E., Martínez-Flórez, S., Pisonero-Vaquero, S., Olcoz, J. L., Jover, R., González-Gallego, J., García-Mediavilla, M. V., & Sánchez-Campos, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.037 · Cited by 524
Xu, B., Jiang, M., Chu, Y., Wang, W., Chen, D., Li, X., Zhang, Z., Zhang, D., Fan, D., Nie, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.040 · Cited by 426
Metadata
- Authors
- Farrell, G. C., Rooyen, D. V., Gan, L., & Chitturi, S.
- Venue
- Gut and Liver
- Published
- 2012-04-15
- Volume
- 6
- Issue
- 2
- Pages
- 149-171
- ISSN
- 1976-2283 (ISSN-L)
- 2005-1212
- OpenAlex
- W2084589154
- Cited by
- 398
- References
- 235
- FWCI
- 26.93
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.